 BALTIMORE--BUSINESS WIRE--- MYMD--MyMD Pharmaceuticals, Inc. Nasdaq: MYMD MyMD or the Company, a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing two therapeutic platforms, today announced that the United States Patent and Trademark Office USPTO has issued U.S. Patent No. 11,096,933 titled Method of Treating Disorders Associated with Chronic Inflammation. The 933 patent becomes the thirteenth patent protecting the Companys lead cand 